A citation-based method for searching scientific literature

Paul T C Wan, Mathew J Garnett, S Mark Roe, Sharlene Lee, Dan Niculescu-Duvaz, Valerie M Good, C Michael Jones, Christopher J Marshall, Caroline J Springer, David Barford, Richard Marais. Cell 2004
Times Cited: 2015



Georgia Hatzivassiliou, Kyung Song, Ivana Yen, Barbara J Brandhuber, Daniel J Anderson, Ryan Alvarado, Mary J C Ludlam, David Stokoe, Susan L Gloor, Guy Vigers, Tony Morales, Ignacio Aliagas, Bonnie Liu, Steve Sideris, Klaus P Hoeflich, Bijay S Jaiswal, Somasekar Seshagiri, Hartmut Koeppen, Marcia Belvin, Lori S Friedman, Shiva Malek. Nature 2010
Times Cited: 1177




List of shared articles



Times cited

Targeting the Non-Catalytic Functions: a New Paradigm for Kinase Drug Discovery?
Zhen Wang, Weixue Huang, Kaijie Zhou, Xiaomei Ren, Ke Ding. J Med Chem 2022
6

AK2 is an AMP-sensing negative regulator of BRAF in tumorigenesis.
Hyunjoo Kim, Muhah Jeong, Do-Hyeong Na, Shin-Hyeon Ryu, Eun Il Jeong, Kwangmin Jung, Jaemin Kang, Ho-June Lee, Taebo Sim, Dae-Yeul Yu,[...]. Cell Death Dis 2022
0

BRAF/MEK inhibition in NSCLC: mechanisms of resistance and how to overcome it.
Ioannis Tsamis, Georgia Gomatou, Stavroula Porfyria Chachali, Ioannis Panagiotis Trontzas, Vasileios Patriarcheas, Emmanouil Panagiotou, Elias Kotteas. Clin Transl Oncol 2022
0

Dermatologic adverse events associated with targeted therapies for melanoma.
Luigi Scarpato, Lucia Festino, Vito Vanella, Gabriele Madonna, Massimo Mastroianni, Marco Palla, Paolo Antonio Ascierto. Expert Opin Drug Saf 2022
0

Harnessing the predictive power of preclinical models for oncology drug development.
Alexander Honkala, Sanjay V Malhotra, Shivaani Kummar, Melissa R Junttila. Nat Rev Drug Discov 2022
7


Recent advances in B-RAF inhibitors as anticancer agents.
Pathan Shahebaaz Khan, Patil Rajesh, Patil Rajendra, Manohar G Chaskar, Arote Rohidas, Sangshetti Jaiprakash. Bioorg Chem 2022
2


Function and evolution of B-Raf loop dynamics relevant to cancer recurrence under drug inhibition.
Gregory A Babbitt, Miranda L Lynch, Matthew McCoy, Ernest P Fokoue, AndrĂ© O Hudson. J Biomol Struct Dyn 2022
6

Design and synthesis of 4-anilinoquinazolines as Raf kinase inhibitors. Part 1. Selective B-Raf/B-RafV600E and potent EGFR/VEGFR2 inhibitory 4-(3-hydroxyanilino)-6-(1H-1,2,3-triazol-4-yl)quinazolines.
Cheng-I Lee, Chu-Bin Liao, Chih-Shang Chen, Fen-Ying Cheng, Yu-Hsuan Chung, Yu-Chuan Wang, Sian-Yi Ciou, Wen-Yun Hsueh, Tzu-Hao Lo, Guan-Ru Huang,[...]. Bioorg Chem 2021
0

Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2.
Sven H Schmidt, Jui-Hung Weng, Phillip C Aoto, Daniela Boassa, Sebastian Mathea, Steve Silletti, Junru Hu, Maximilian Wallbott, Elizabeth A Komives, Stefan Knapp,[...]. Proc Natl Acad Sci U S A 2021
11

New insights into Raf regulation from structural analyses.
Yasushi Kondo, Joseph W Paul, Sriram Subramaniam, John Kuriyan. Curr Opin Struct Biol 2021
2